Mutation in the DNA gyrase A gene of Escherichia coli that expands the quinolone resistance-determining region

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 8, 2001, Pages 2378-2380

  Friedman, S M ^a   Lu, T ^a   Drlica, K ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GATIFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ESCHERICHIA COLI; GENE MUTATION; GENE STRUCTURE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL;

4-QUINOLONES; ANTI-INFECTIVE AGENTS; DNA GYRASE; DNA PRIMERS; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; MUTATION; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION;

EID: 0034925137     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.8.2378-2380.2001     Document Type: Article

References (22)

1. Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin
2. Thermotolerant nalidixic acid-resistant mutants of Escherichia coli
3. DNA supercoiling in a thermotolerant mutant of Escherichia coli
4. Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: Novel mutations suggest novel drug-target interactions
5. Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from worldwide surveillance studies during the 1997-1998 respiratory season
6. Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa
7. Gatifloxacin activity, against quinolone-resistant gyrase: Allele-specific enhancement of bacteriostatic and bactericidal activity by the C-8-methoxy group
8. Crystal structure of the breakage-reunion domain of DNA gyrase
9. Mechanisms of quinolone resistance
10. Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates
11. Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria
12. A collection of strains containing genetically linked alternating antibiotic resistance elements for genetic mapping of Escherichia coli
13. Mutations in the gene coding for Escherichia coli DNA topoisomerase I affecting transcription and transposition
14. Emergence of fluoroquinolone-resistant tuberculosis in New York City
15. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in gyrA, with or without substitutions in parC, to newer fluoroquinolones and other antibiotics
16. Phage P1 mutants with altered transducing abilities for Escherichia coli
17. Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea
18. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
19. DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
20. Selection of antibiotic resistance: Allelic diversity among fluoroquinolone-resistant mutations